LTRN logo

Lantern Pharma (LTRN) Cash From Investing

Annual CFI

-$930.20 K
-$1.11 M-618.80%

December 31, 2023


Summary


Performance

LTRN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLTRNcash flowmetrics:

Quarterly CFI

$680.30 K
+$882.40 K+436.62%

September 30, 2024


Summary


Performance

LTRN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLTRNcash flowmetrics:

TTM CFI

$178.20 K
+$448.60 K+165.90%

September 30, 2024


Summary


Performance

LTRN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLTRNcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

LTRN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-618.8%+193.6%+130.5%
3 y3 years-5677.6%+167.9%+100.9%
5 y5 years-10000.0%+10000.0%+3226.3%

LTRN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-618.8%+95.2%at high+170.8%-0.6%+100.9%
5 y5-year-618.8%+95.2%at high+103.7%-0.6%+100.9%
alltimeall time-618.8%+95.2%at high+103.7%-0.6%+100.9%

Lantern Pharma Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$680.30 K(-436.6%)
$178.20 K(-165.9%)
Jun 2024
-
-$202.10 K(-63.7%)
-$270.40 K(-48.5%)
Mar 2024
-
-$556.20 K(-317.1%)
-$525.50 K(-43.5%)
Dec 2023
-$930.20 K(-618.8%)
$256.20 K(+10.6%)
-$930.20 K(+59.4%)
Sep 2023
-
$231.70 K(-150.7%)
-$583.50 K(-34.4%)
Jun 2023
-
-$457.20 K(-52.4%)
-$889.60 K(-7.1%)
Mar 2023
-
-$960.90 K(-259.4%)
-$958.10 K(-634.4%)
Dec 2022
$179.30 K(-100.9%)
$602.90 K(-910.3%)
$179.30 K(-127.3%)
Sep 2022
-
-$74.40 K(-85.8%)
-$657.60 K(-58.5%)
Jun 2022
-
-$525.70 K(-397.8%)
-$1.59 M(-91.8%)
Mar 2022
-
$176.50 K(-175.4%)
-$19.35 M(-0.9%)
DateAnnualQuarterlyTTM
Dec 2021
-$19.53 M(>+9900.0%)
-$234.00 K(-76.7%)
-$19.53 M(+1.2%)
Sep 2021
-
-$1.00 M(-94.5%)
-$19.30 M(+5.5%)
Jun 2021
-
-$18.29 M(<-9900.0%)
-$18.30 M(>+9900.0%)
Mar 2021
-
$0.00(-100.0%)
-$16.10 K(0.0%)
Dec 2020
-$16.10 K(+182.5%)
-$5000.00(+51.5%)
-$16.10 K(+45.0%)
Sep 2020
-
-$3300.00(-57.7%)
-$11.10 K(-17.8%)
Jun 2020
-
-$7800.00(<-9900.0%)
-$13.50 K(+136.8%)
Dec 2019
-$5700.00(-207.5%)
$0.00(-100.0%)
-$5700.00(0.0%)
Sep 2019
-
-$5700.00(<-9900.0%)
-$5700.00(<-9900.0%)
Jun 2019
-
$0.00
$0.00
Dec 2018
$5300.00
-
-

FAQ

  • What is Lantern Pharma annual cash flow from investing activities?
  • What is the all time high annual CFI for Lantern Pharma?
  • What is Lantern Pharma annual CFI year-on-year change?
  • What is Lantern Pharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Lantern Pharma?
  • What is Lantern Pharma quarterly CFI year-on-year change?
  • What is Lantern Pharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Lantern Pharma?
  • What is Lantern Pharma TTM CFI year-on-year change?

What is Lantern Pharma annual cash flow from investing activities?

The current annual CFI of LTRN is -$930.20 K

What is the all time high annual CFI for Lantern Pharma?

Lantern Pharma all-time high annual cash flow from investing activities is $179.30 K

What is Lantern Pharma annual CFI year-on-year change?

Over the past year, LTRN annual cash flow from investing activities has changed by -$1.11 M (-618.80%)

What is Lantern Pharma quarterly cash flow from investing activities?

The current quarterly CFI of LTRN is $680.30 K

What is the all time high quarterly CFI for Lantern Pharma?

Lantern Pharma all-time high quarterly cash flow from investing activities is $680.30 K

What is Lantern Pharma quarterly CFI year-on-year change?

Over the past year, LTRN quarterly cash flow from investing activities has changed by +$448.60 K (+193.61%)

What is Lantern Pharma TTM cash flow from investing activities?

The current TTM CFI of LTRN is $178.20 K

What is the all time high TTM CFI for Lantern Pharma?

Lantern Pharma all-time high TTM cash flow from investing activities is $179.30 K

What is Lantern Pharma TTM CFI year-on-year change?

Over the past year, LTRN TTM cash flow from investing activities has changed by +$761.70 K (+130.54%)